COVID-19
Conditions
Keywords
COVID-19, Oral Nutrition Supplement
Brief summary
The goal of this clinical trial is to determine effect of arginine and glutamine on outcome of COVID-19 patients. The main questions it aims to answer are: -to test the effect of oral nutritional supplements containing arginine and glutamine on covid-19 patients outcome Dr. M. Djamil General Hospital Padang Participants will given ONS containing arginine and glutamine. Researchers will compare intervention group with control group to see if ONS affected outcome of COVID-19 patients
Interventions
DIETARY_SUPPLEMENTNeomune
Neomune containing 4.8 g arginine and 2 g glutamine
Sponsors
M. Djamil General Hospital
Universitas Sriwijaya
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Patients confirmed positive for COVID-19 * Age over 17 years * The patient can take food orally
Exclusion criteria
* Patients with restricted fluid intake * Patients who cannot take food orally * suffering from diabetes mellitus and kidney failure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| length of stay | 3 months | length of stay of patients in hospital |
| Outcome | 3 months | Outcome Measures of patients (discharge or dead) |
| ICU Admission | 3 months | A patient is likely to be admitted to ICU during intervention period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Il-6 and CRP Levels | 3 months | Il-6 and CRP Levels during hospitalization |
Countries
Indonesia
Outcome results
None listed